• Login
    Browsing All Christie Publications by Authors 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • Browsing All Christie Publications by Authors
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • Browsing All Christie Publications by Authors
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Browsing All Christie Publications by Authors

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    xmlui.ArtifactBrowser.ConfigurableBrowse.view

    Sort by:

    Order:

    Results:

    Now showing items 1-2 of 2

    • List view
    • Grid view
    • title
    • issue date
    • submit date
    • ascending
    • descending
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Thumbnail

        Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: Results from the ETOP Lungscape Project.

        Letovanec, I; Finn, S; Zygoura, P; Smyth, P; Soltermann, A; Bubendorf, L; Speel, E; Marchetti, A; Nonaka, Daisuke; Monkhorst, K; et al. (2017-11-27)
        The reported prevalence of ALK rearrangement in NSCLC ranges from 2%-7%. The primary standard diagnostic method is fluorescence in situ hybridization (FISH). Recently, immunohistochemistry (IHC) has also proven to be a reproducible and sensitive technique. Reverse transcriptase-polymerase chain reaction (RT-PCR) has also been advocated and most recently the advent of targeted Next-Generation Sequencing (NGS) for ALK and other fusions has become possible. This study compares ALK evaluation with all 4 techniques in resected NSCLC from the large ETOP Lungscape cohort.
      • Thumbnail

        Patient-reported outcomes (PROs) with durvalumab by PD-L1 expression in unresectable, stage III NSCLC (PACIFIC)

        Garassino, MC; Paz-Ares, L; Hui, R; Faivre-Finn, Corinne; Spira, A; Planchard, D; Ozguroglu, M; Daniel, DB; Vicente, D; Murakami, S; et al. (2019)
        DSpace software (copyright © 2002 - 2022)  DuraSpace
        Quick Guide | Contact Us
        Open Repository is a service operated by 
        Atmire NV
         

        Export search results

        The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

        By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

        To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

        After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.